36 results
8-K
EX-99.1
RLYB
Rallybio Corp
9 Nov 23
Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
8:10am
this study, including our indication strategy, prior to the end of 2023. In parallel, we continue to advance our preclinical programs albeit with a focus
8-K
EX-99.1
ej1jxjz2
8 Aug 23
Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
8:16am
8-K
vnzi6
29 Jun 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
s51p1u w696ye3wl
29 Jun 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
k6mvvae712vg
9 May 23
Rallybio Reports First Quarter 2023 Financial Results
8:11am
424B5
6yq5aw8
14 Nov 22
Prospectus supplement for primary offering
8:02am
424B5
bahxxt3s
10 Nov 22
Prospectus supplement for primary offering
9:23am
8-K
EX-99.1
bweafqevht3tj
2 Aug 22
Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
8:30am
8-K
EX-99.1
ewj1 l9bnhb09y
10 May 22
Rallybio Reports First Quarter 2022 Financial Results
4:01pm